These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 20429782)

  • 1. Design, synthesis and anti-Parkinsonian evaluation of 3-alkyl/aryl-8-(furan-2-yl)thiazolo[5,4-e][1,2,4]triazolo[1,5-c]pyrimidine-2(3H)-thiones against neuroleptic-induced catalepsy and oxidative stress in mice.
    Azam F; El-gnidi BA; Alkskas IA; Ahmed MA
    J Enzyme Inhib Med Chem; 2010 Dec; 25(6):818-26. PubMed ID: 20429782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis of some urea and thiourea derivatives of 3-phenyl/ethyl-2-thioxo-2,3-dihydrothiazolo[4,5-d]pyrimidine and their antagonistic effects on haloperidol-induced catalepsy and oxidative stress in mice.
    Azam F; Alkskas IA; Ahmed MA
    Eur J Med Chem; 2009 Oct; 44(10):3889-97. PubMed ID: 19447524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroprotective effect of naphtha[1,2-d]thiazol-2-amine in an animal model of Parkinson's disease.
    Azam F; Barodia SK; Anwer T; Alam MM
    J Enzyme Inhib Med Chem; 2009 Jun; 24(3):808-17. PubMed ID: 18846462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combating oxidative stress in epilepsy: design, synthesis, quantum chemical studies and anticonvulsant evaluation of 1-(substituted benzylidene/ethylidene)-4-(naphthalen-1-yl)semicarbazides.
    Azam F; El-Gnidi BA; Alkskas IA
    Eur J Med Chem; 2010 Jul; 45(7):2817-26. PubMed ID: 20356656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel 8-(furan-2-yl)-3-substituted thiazolo [5,4-e][1,2,4] triazolo[1,5-c] pyrimidine-2(3H)-thione derivatives as potential adenosine A(2A) receptor antagonists.
    Mishra CB; Barodia SK; Prakash A; Senthil Kumar JB; Luthra PM
    Bioorg Med Chem; 2010 Apr; 18(7):2491-500. PubMed ID: 20303771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-based design, synthesis and molecular modeling studies of thiazolyl urea derivatives as novel anti-parkinsonian agents.
    Azam F; Prasad MV; Thangavel N; Shrivastava AK; Mohan G
    Med Chem; 2012 Nov; 8(6):1057-68. PubMed ID: 22741780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis of some novel thiourea derivatives obtained from 5-[(4-aminophenoxy)methyl]-4-alkyl/aryl-2,4-dihydro-3H-1,2,4-triazole-3-thiones and evaluation as antiviral/anti-HIV and anti-tuberculosis agents.
    Küçükgüzel I; Tatar E; Küçükgüzel SG; Rollas S; De Clercq E
    Eur J Med Chem; 2008 Feb; 43(2):381-92. PubMed ID: 17583388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 2-(2-Furanyl)-7-phenyl[1,2,4]triazolo[1,5-c]pyrimidin-5-amine analogs: highly potent, orally active, adenosine A2A antagonists. Part 1.
    Matasi JJ; Caldwell JP; Zhang H; Fawzi A; Cohen-Williams ME; Varty GB; Tulshian DB
    Bioorg Med Chem Lett; 2005 Aug; 15(16):3670-4. PubMed ID: 15978806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Behavioral alterations in rotenone model of Parkinson's disease: attenuation by co-treatment of centrophenoxine.
    Nehru B; Verma R; Khanna P; Sharma SK
    Brain Res; 2008 Mar; 1201():122-7. PubMed ID: 18308296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potent, selective, and orally active adenosine A2A receptor antagonists: arylpiperazine derivatives of pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidines.
    Neustadt BR; Hao J; Lindo N; Greenlee WJ; Stamford AW; Tulshian D; Ongini E; Hunter J; Monopoli A; Bertorelli R; Foster C; Arik L; Lachowicz J; Ng K; Feng KI
    Bioorg Med Chem Lett; 2007 Mar; 17(5):1376-80. PubMed ID: 17236762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Piperazine derivatives of [1,2,4]triazolo[1,5-a][1,3,5]triazine as potent and selective adenosine A2a receptor antagonists.
    Vu CB; Peng B; Kumaravel G; Smits G; Jin X; Phadke D; Engber T; Huang C; Reilly J; Tam S; Grant D; Hetu G; Chen L; Zhang J; Petter RC
    J Med Chem; 2004 Aug; 47(17):4291-9. PubMed ID: 15294001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective effect of unsymmetrical dichalcogenide, a novel antioxidant agent, in vitro and an in vivo model of brain oxidative damage.
    Prigol M; Wilhelm EA; Schneider CC; Nogueira CW
    Chem Biol Interact; 2008 Nov; 176(2-3):129-36. PubMed ID: 18722362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, synthesis, and biological evaluation of C9- and C2-substituted pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidines as new A2A and A3 adenosine receptors antagonists.
    Baraldi PG; Fruttarolo F; Tabrizi MA; Preti D; Romagnoli R; El-Kashef H; Moorman A; Varani K; Gessi S; Merighi S; Borea PA
    J Med Chem; 2003 Mar; 46(7):1229-41. PubMed ID: 12646033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Indolalkylamines derivatives as antioxidant and neuroprotective agents in an experimental model of Parkinson's disease.
    Sanz E; Romera M; Bellik L; Marco JI; Unzeta M
    Med Sci Monit; 2004 Dec; 10(12):BR477-84. PubMed ID: 15567979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lead optimization of 4-acetylamino-2-(3,5-dimethylpyrazol-1-yl)-6-pyridylpyrimidines as A2A adenosine receptor antagonists for the treatment of Parkinson's disease.
    Zhang X; Tellew JE; Luo Z; Moorjani M; Lin E; Lanier MC; Chen Y; Williams JP; Saunders J; Lechner SM; Markison S; Joswig T; Petroski R; Piercey J; Kargo W; Malany S; Santos M; Gross RS; Wen J; Jalali K; O'Brien Z; Stotz CE; Crespo MI; Díaz JL; Slee DH
    J Med Chem; 2008 Nov; 51(22):7099-110. PubMed ID: 18947224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies on adenosine A2a receptor antagonists: comparison of three core heterocycles.
    Vu CB; Pan D; Peng B; Sha L; Kumaravel G; Jin X; Phadke D; Engber T; Huang C; Reilly J; Tam S; Petter RC
    Bioorg Med Chem Lett; 2004 Oct; 14(19):4831-4. PubMed ID: 15341933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Withania somnifera root extract on haloperidol-induced catalepsy in albino mice.
    Nair V; Arjuman A; Gopalakrishna HN; Nandini M
    Phytother Res; 2008 Feb; 22(2):243-6. PubMed ID: 17886228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The significance of 2-furyl ring substitution with a 2-(para-substituted) aryl group in a new series of pyrazolo-triazolo-pyrimidines as potent and highly selective hA(3) adenosine receptors antagonists: new insights into structure-affinity relationship and receptor-antagonist recognition.
    Cheong SL; Dolzhenko A; Kachler S; Paoletta S; Federico S; Cacciari B; Dolzhenko A; Klotz KN; Moro S; Spalluto G; Pastorin G
    J Med Chem; 2010 Apr; 53(8):3361-75. PubMed ID: 20307065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of centrophenoxine against rotenone-induced oxidative stress in an animal model of Parkinson's disease.
    Verma R; Nehru B
    Neurochem Int; 2009 Nov; 55(6):369-75. PubMed ID: 19375462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel antipsychotic agents with 5-HT(1A) agonist properties: role of 5-HT(1A) receptor activation in attenuation of catalepsy induction in rats.
    Kleven MS; Barret-Grévoz C; Bruins Slot L; Newman-Tancredi A
    Neuropharmacology; 2005 Aug; 49(2):135-43. PubMed ID: 15996562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.